Thank you, Mr. Chair.
I'd like to thank the witnesses for being with us today and for sharing their expertise with us. This has been very interesting.
I will start with Ms. Caprani.
You spoke a little bit about the trickle-down of the impacts on countries, outside of the vaccines. One big concern that I am feeling with this is, first of all, that the world has changed focus. Now that the developed world or the countries in the north have reached fourth doses and have increased their vaccination, there is this feeling that COVID-19 is over and that we can change the channel or turn the page. I think both of our witnesses today have made it very clear that we are not out of this pandemic and that variants will continue to develop.
One worry of mine is that ODA will be impacted. Countries will see their vaccines as a portion of their ODA, which means fewer ODA dollars will be available for things like other health care initiatives, education and support for women and girls.
Can you speak about whether or not that worry is founded, and what we can do to prevent it?